Bodal Chemicals Limited
Bodal Chemicals Limited engages in the manufacture and sale of dyestuffs, dyes intermediates, and other chemicals in India. The company's dye intermediates primarily include H-Acid, vinyl sulphone, K-Acid, gamma acid, DASA, FC acid, SPVS, OA sulpho VS, and beta naphthol; and dyestuffs, such as reactive dyes, acid dyes, direct dyes, and liquid dyes. It also provides chemicals comprising of sulphur… Read more
Bodal Chemicals Limited (BODALCHEM) - Net Assets
Latest net assets as of September 2025: ₹11.22 Billion INR
Based on the latest financial reports, Bodal Chemicals Limited (BODALCHEM) has net assets worth ₹11.22 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹23.13 Billion) and total liabilities (₹11.91 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹11.22 Billion |
| % of Total Assets | 48.51% |
| Annual Growth Rate | 21.32% |
| 5-Year Change | 12.75% |
| 10-Year Change | 370.95% |
| Growth Volatility | 33.58 |
Bodal Chemicals Limited - Net Assets Trend (2006–2025)
This chart illustrates how Bodal Chemicals Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bodal Chemicals Limited (2006–2025)
The table below shows the annual net assets of Bodal Chemicals Limited from 2006 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹11.05 Billion | +2.09% |
| 2024-03-31 | ₹10.82 Billion | +0.42% |
| 2023-03-31 | ₹10.78 Billion | +2.41% |
| 2022-03-31 | ₹10.52 Billion | +7.39% |
| 2021-03-31 | ₹9.80 Billion | +4.61% |
| 2020-03-31 | ₹9.37 Billion | +12.82% |
| 2019-03-31 | ₹8.30 Billion | +18.94% |
| 2018-03-31 | ₹6.98 Billion | +93.36% |
| 2017-03-31 | ₹3.61 Billion | +53.89% |
| 2016-03-31 | ₹2.35 Billion | +29.26% |
| 2015-03-31 | ₹1.81 Billion | +101.90% |
| 2014-03-31 | ₹898.93 Million | +76.80% |
| 2013-03-31 | ₹508.45 Million | -13.01% |
| 2012-03-31 | ₹584.46 Million | -26.61% |
| 2011-03-31 | ₹796.43 Million | +37.61% |
| 2010-03-31 | ₹578.77 Million | +14.10% |
| 2009-03-31 | ₹507.24 Million | +7.29% |
| 2008-03-31 | ₹472.79 Million | +32.35% |
| 2007-03-31 | ₹357.23 Million | +27.09% |
| 2006-03-31 | ₹281.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bodal Chemicals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 735441000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹7.35 Billion | 66.56% |
| Common Stock | ₹251.89 Million | 2.28% |
| Other Comprehensive Income | ₹979.70 Million | 8.87% |
| Other Components | ₹2.46 Billion | 22.29% |
| Total Equity | ₹11.05 Billion | 100.00% |
Bodal Chemicals Limited Competitors by Market Cap
The table below lists competitors of Bodal Chemicals Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Isrotel -L
TA:ISRO
|
$25.08 Million |
|
Golden Insurance Brokers Co.,Ltd.
TWO:6028
|
$25.08 Million |
|
Locksley Resources Ltd
AU:LKY
|
$25.09 Million |
|
Dongkook Ind
KO:001620
|
$25.09 Million |
|
GavYam Lands Corp Ltd
TA:GVYM
|
$25.05 Million |
|
Toplus Global Co Ltd
TWO:3522
|
$25.05 Million |
|
ZK International Group Co Ltd
NASDAQ:ZKIN
|
$25.04 Million |
|
Vilniaus Baldai AB
MU:UE3
|
$25.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bodal Chemicals Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,822,410,000 to 11,048,470,000, a change of 226,060,000 (2.1%).
- Net income of 185,020,000 contributed positively to equity growth.
- Dividend payments of 610,000 reduced retained earnings.
- Share repurchases of 1,550,000 reduced equity.
- New share issuances of 1,550,000 increased equity.
- Other comprehensive income decreased equity by 34,320,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹185.02 Million | +1.67% |
| Dividends Paid | ₹610.00K | -0.01% |
| Share Repurchases | ₹1.55 Million | -0.01% |
| Share Issuances | ₹1.55 Million | +0.01% |
| Other Comprehensive Income | ₹-34.32 Million | -0.31% |
| Other Changes | ₹75.97 Million | +0.69% |
| Total Change | ₹- | 2.09% |
Book Value vs Market Value Analysis
This analysis compares Bodal Chemicals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.50x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 11.01x to 0.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | ₹3.95 | ₹43.52 | x |
| 2007-03-31 | ₹6.87 | ₹43.52 | x |
| 2008-03-31 | ₹6.62 | ₹43.52 | x |
| 2009-03-31 | ₹6.41 | ₹43.52 | x |
| 2010-03-31 | ₹5.82 | ₹43.52 | x |
| 2011-03-31 | ₹7.95 | ₹43.52 | x |
| 2012-03-31 | ₹5.61 | ₹43.52 | x |
| 2013-03-31 | ₹4.62 | ₹43.52 | x |
| 2014-03-31 | ₹8.24 | ₹43.52 | x |
| 2015-03-31 | ₹16.63 | ₹43.52 | x |
| 2016-03-31 | ₹21.50 | ₹43.52 | x |
| 2017-03-31 | ₹32.93 | ₹43.52 | x |
| 2018-03-31 | ₹60.69 | ₹43.52 | x |
| 2019-03-31 | ₹67.83 | ₹43.52 | x |
| 2020-03-31 | ₹76.26 | ₹43.52 | x |
| 2021-03-31 | ₹80.08 | ₹43.52 | x |
| 2022-03-31 | ₹86.18 | ₹43.52 | x |
| 2023-03-31 | ₹85.84 | ₹43.52 | x |
| 2024-03-31 | ₹85.32 | ₹43.52 | x |
| 2025-03-31 | ₹87.73 | ₹43.52 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bodal Chemicals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.06%
- • Asset Turnover: 0.74x
- • Equity Multiplier: 2.13x
- Recent ROE (1.67%) is below the historical average (16.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 8.67% | 1.66% | 1.58x | 3.31x | ₹-3.75 Million |
| 2007 | 31.27% | 4.39% | 1.50x | 4.73x | ₹75.98 Million |
| 2008 | 36.91% | 4.31% | 1.38x | 6.22x | ₹127.22 Million |
| 2009 | -21.95% | -2.82% | 1.21x | 6.43x | ₹-162.08 Million |
| 2010 | 23.26% | 2.88% | 1.05x | 7.72x | ₹76.76 Million |
| 2011 | 22.18% | 3.13% | 1.02x | 6.97x | ₹96.31 Million |
| 2012 | 51.50% | 4.86% | 1.07x | 9.92x | ₹240.41 Million |
| 2013 | -46.10% | -4.39% | 1.11x | 9.45x | ₹-282.81 Million |
| 2014 | 33.55% | 3.14% | 1.62x | 6.59x | ₹211.74 Million |
| 2015 | 50.57% | 8.86% | 1.94x | 2.94x | ₹736.33 Million |
| 2016 | 36.65% | 9.45% | 1.78x | 2.17x | ₹625.27 Million |
| 2017 | 35.79% | 10.40% | 1.77x | 1.94x | ₹926.58 Million |
| 2018 | 17.58% | 10.84% | 1.05x | 1.54x | ₹528.64 Million |
| 2019 | 17.27% | 10.24% | 1.08x | 1.57x | ₹602.63 Million |
| 2020 | 9.35% | 6.40% | 0.93x | 1.58x | ₹-60.17 Million |
| 2021 | 4.28% | 3.44% | 0.70x | 1.78x | ₹-561.60 Million |
| 2022 | 9.87% | 5.14% | 0.95x | 2.01x | ₹-13.52 Million |
| 2023 | 3.53% | 2.43% | 0.74x | 1.97x | ₹-697.37 Million |
| 2024 | 0.60% | 0.46% | 0.61x | 2.11x | ₹-1.02 Billion |
| 2025 | 1.67% | 1.06% | 0.74x | 2.13x | ₹-919.83 Million |
Industry Comparison
This section compares Bodal Chemicals Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,571,777,102
- Average return on equity (ROE) among peers: 15.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bodal Chemicals Limited (BODALCHEM) | ₹11.22 Billion | 8.67% | 1.06x | $25.07 Million |
| Aarti Industries Limited (AARTIIND) | $8.75 Billion | 18.56% | 2.05x | $1.01 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $15.14 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $294.24K |
| ACUTAAS CHEMICALS LTD (ACUTAAS) | $5.94 Billion | 14.02% | 0.29x | $247.08K |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $984.09 Million | 34.30% | 2.55x | $95.16 Million |
| Agarwal Industrial Corporation Limited (AGARIND) | $739.40 Million | 9.29% | 0.98x | $26.89 Million |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $1.88 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $3.79 Billion | 22.71% | 1.01x | $204.91 Million |
| Ami Organics Limited (AMIORG) | $107.73 Million | 26.58% | 2.59x | $704.27 Million |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $318.75 Million |